NCT03749993View on ClinicalTrials.gov

Evaluation of a MRI-based Prostate Cancer Screening Program

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2023

Conditions
Prostate Cancer
Interventions
OTHER

Screening

Use of bpMRI for opportunistic prostate cancer screening.

Trial Locations (1)

4031

University Hospital Basel, Clinic of Urology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03749993 - Evaluation of a MRI-based Prostate Cancer Screening Program | Biotech Hunter | Biotech Hunter